GYRENasdaq

GYRE THERAPEUTICS, INC.

Alert me on GYRE

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Jun 23 Sale Ye Weiguo Insider

1 week

+7.5%S&P +1.8%

1 month

−2.0%S&P +0.6%

3 months

+22.2%S&P +5.7%

6 months

Result in29 trading days

Jun 16 Sale Ye Weiguo Insider

1 week

+11.3%S&P −2.0%

1 month

+4.0%S&P −0.7%

3 months

+15.1%S&P +0.8%

6 months

Result in25 trading days

Jun 12 Sale Ye Weiguo Insider

1 week

+3.4%S&P +0.6%

1 month

+10.6%S&P +2.0%

3 months

+12.8%S&P +2.8%

6 months

Result in23 trading days

Jun 9 Sale Ye Weiguo Insider

1 week

−5.1%S&P +1.8%

1 month

+6.4%S&P +2.7%

3 months

+13.4%S&P +3.7%

6 months

Result in20 trading days

May 28 Sale Ye Weiguo Insider

1 week

+7.8%S&P +0.3%

1 month

+12.4%S&P −1.6%

3 months

+16.4%S&P +2.4%

6 months

Result in12 trading days

Show all 9

May 23 Sale Ye Weiguo Insider

1 week

−6.4%S&P +1.2%

1 month

+4.9%S&P −1.9%

3 months

+12.5%S&P +2.3%

6 months

Result in10 trading days

May 21 Sale Ye Weiguo Insider

1 week

−4.4%S&P +1.9%

1 month

−0.8%S&P −1.0%

3 months

+11.8%S&P +3.4%

6 months

Result in8 trading days

May 19 Sale Ye Weiguo Insider

1 week

−5.4%S&P +2.3%

1 month

−0.2%S&P +2.0%

3 months

+14.2%S&P +5.1%

6 months

Result in6 trading days

May 8 Sale Luo Ying Insider

1 week

−12.3%S&P +0.2%

1 month

−17.9%S&P −0.1%

3 months

−10.0%S&P +5.1%

6 months

−36.3%S&P +0.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for GYRE

29 held · newest 529 held · newest 2

Loading the filings.

See all 29 filings for GYRE

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.